Tokyo, Japan

Miki Yokozawa

This inventor holds 1 USPTO granted patent. Top assignees: Nutrition Act Co., Ltd., University of Tsukuba. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miki Yokozawa. Retrieved from https://idiyas.com/inventor/miki-yokozawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miki Yokozawa: Innovator in HIF-1 Activation

Introduction

Miki Yokozawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly with his work on HIF-1 activators. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Miki Yokozawa holds a patent for a HIF-1 activator. This invention is crucial in the study of cellular responses to hypoxia and has potential applications in various medical fields. His patent portfolio includes 1 patent, reflecting his focused contributions to innovation.

Career Highlights

Throughout his career, Miki has worked with esteemed institutions such as the University of Tsukuba and Nutrition Act Co., Ltd. His experiences in these organizations have allowed him to collaborate with leading experts and contribute to groundbreaking research.

Collaborations

Miki Yokozawa has collaborated with notable individuals in his field, including Masahito Ishikawa and Farhana Ferdousi. These partnerships have enriched his work and expanded the impact of his inventions.

Conclusion

Miki Yokozawa is a distinguished inventor whose work on HIF-1 activators has made a significant impact in biotechnology. His career reflects a commitment to innovation and collaboration, positioning him as a key figure in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…